link 4/27/2010- Teva Pharmaceuticals' (NASDAQ:TEVA) Parental Medicines unit failed to correct manufacturing problems at its facility in Irvine, California that caused contamination in batches of an anesthetic, according to federal regulators.Who owns TEVA? Answer:
The FDA sent a warning letter in December citing contamination with batches of pharmaceuticals made at the facility. It warned over a failure to correct issues with bacterial endotoxin contamination found in vials of propofol injectable emulsion, which is used in general anesthesia. The lot was recalled.
The agency also warned about a failure to clean and sanitize equipment and utensils at appropriate intervals to prevent contamination.
Teva Pharmaceutical Industries Ltd. (Hebrew: טבע תעשיות פרמצבטיות בע"מ), NASDAQ: TEVA is an international pharmaceutical company headquartered in Petah Tikva, Israel. It specializes in generic and proprietary pharmaceuticals and active pharmaceutical ingredients. It is among the largest generic drug manufacturers in the world and one of the 20 largest pharmaceutical companies worldwide